Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

399 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Telehealth exercise for continence after gynaecological cancer treatment (TELE-CONNECT): a protocol for a co-designed pragmatic randomised controlled trial.
Frawley HC, Bennell K, Nelligan RK, Ravi A, Susanto N, Hyde S, McNally O, Yao SE, Lamb KE, Li P, Denehy L; TELE-CONNECT study team. Frawley HC, et al. Among authors: hyde s. BMC Womens Health. 2024 Sep 27;24(1):529. doi: 10.1186/s12905-024-03365-9. BMC Womens Health. 2024. PMID: 39334122 Free PMC article. Clinical Trial.
Pharmacological and pre-clinical safety profile of rSIV.F/HN, a hybrid lentiviral vector for cystic fibrosis gene therapy.
Moiseenko A, Sinadinos A, Sergijenko A, Pineault K, Saleh A, Nekola K, Strang N, Eleftheraki A, Boyd AC, Davies JC, Gill DR, Hyde SC, McLachlan G, Rath T, Rothe M, Schambach A, Hobbie S, Schuler M, Maier U, Thomas MJ, Mennerich D, Schmidt M, Griesenbach U, Alton EWFW, Kreuz S. Moiseenko A, et al. Among authors: hyde sc. Eur Respir J. 2024 Nov 21:2301683. doi: 10.1183/13993003.01683-2023. Online ahead of print. Eur Respir J. 2024. PMID: 39174284 Free article.
BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance.
Nesic K, Krais JJ, Wang Y, Vandenberg CJ, Patel P, Cai KQ, Kwan T, Lieschke E, Ho GY, Barker HE, Bedo J, Casadei S, Farrell A, Radke M, Shield-Artin K, Penington JS, Geissler F, Kyran E, Betsch R, Xu L, Zhang F, Dobrovic A, Olesen I, Kristeleit R, Oza A, McNeish I, Ratnayake G, Traficante N; Australian Ovarian Cancer Study; DeFazio A, Bowtell DDL, Harding TC, Lin K, Swisher EM, Kondrashova O, Scott CL, Johnson N, Wakefield MJ. Nesic K, et al. Mol Cancer. 2024 Aug 5;23(1):158. doi: 10.1186/s12943-024-02048-1. Mol Cancer. 2024. PMID: 39103848 Free PMC article.
Incorporating patient-reported outcome measures (PROMs) into a clinical quality registry (CQR) for ovarian cancer: considerations and challenges.
Lefkovits YR, Heriot N, Sporik A, Perera S, Friedlander M, Dixon C, Cohen PA, Lee YC, Hyde S, Richardson G, Webb P, Rome R, King M, Zalcberg J, Schofield P. Lefkovits YR, et al. Among authors: hyde s. BMC Health Serv Res. 2024 Jul 8;24(1):778. doi: 10.1186/s12913-024-11042-8. BMC Health Serv Res. 2024. PMID: 38978033 Free PMC article. Review.
Prioritization of Randomized Clinical Trial Questions for Children Hospitalized With Common Conditions: A Consensus Statement.
Coon ER, McDaniel CE, Paciorkowski N, Grimshaw M, Frakes E, Ambroggio L, Auger KA, Cohen E, Garber M, Gill PJ, Jennings R, Joshi NS, Leyenaar JK, McCulloh R, Pantell MS, Sauers-Ford HS, Schroeder AR, Srivastava R, Wang ME, Wilson KM, Kaiser SV; RCT conference series group. Coon ER, et al. JAMA Netw Open. 2024 May 1;7(5):e2411259. doi: 10.1001/jamanetworkopen.2024.11259. JAMA Netw Open. 2024. PMID: 38748429 Free article.
GripAble: Interrater reliability and normative grip strength of UK population.
Mutalib SA, Sharma D, Pike S, Gwynne L, Hyde S, Morehouse J, Davey H, Edwards L, Douglass-Kirk P, Burdet E, Goldsmith N, Mace M. Mutalib SA, et al. Among authors: hyde s. J Hand Ther. 2024 Mar 22:S0894-1130(23)00201-6. doi: 10.1016/j.jht.2023.12.013. Online ahead of print. J Hand Ther. 2024. PMID: 38521687 Free article.
399 results